Clinical Trials Logo

Dysfunction clinical trials

View clinical trials related to Dysfunction.

Filter by:
  • None
  • Page 1

NCT ID: NCT06148077 Not yet recruiting - Clinical trials for Head and Neck Cancer

Manual Therapy for Oral Health on Head and Neck Cancer Survivors

MaTeO
Start date: March 1, 2024
Phase: N/A
Study type: Interventional

Trismus has been reported as the second most common comorbidity in survivors of head and neck cancer (HNC). It is mainly associated with post-radiotherapy subcutaneous fibrosis, muscular atrophy, damage to neurological structures in the neck, or a combination of all, affecting masticatory musculature. In addition to this, the loss of flexibility and strength in the shoulder has also been shown to be related to deficits in the function and quality of life of these patients. The goal of this clinical trial is to determinate the effectiveness and safety of Manual Therapy (MT) on oral health, as well as the mobility of the upper quarter, the strength of cervical musculature, pain, functionality, and the perception of quality of life in head and neck cancer survivors. Participants will be assigned randomly to the study groups: a) manual therapy program and control motor exercises, b) control motor exercises (usual care) and, c) waiting list. The assessment refers to a baseline form (at the beginning of the study), at 6 weeks and at 6 weeks of patient follow-up.

NCT ID: NCT04860622 Completed - Pregnancy Related Clinical Trials

Normal Range of TSH and FT4 in Pregnancy

NRTSHTURKEY
Start date: April 1, 2021
Phase:
Study type: Observational [Patient Registry]

Physiological changes necessitate the use of pregnancy-specific reference ranges for thyrotrophin (TSH) and free T4 (FT4) to diagnose thyroid dysfunction during pregnancy. Although many centers use fixed upper limits for TSH of 2.5 or 3.0 mU/L, this may lead to overdiagnosis or even overtreatment. The new guidelines of the American Thyroid Association have considerably changed recommendations regarding thyroid function reference ranges in pregnancy accordingly. Any hospital or physician that is still using the 2.5 or 3.0 mU/l cut-off for TSH during pregnancy should evaluate their own lab-specific cut-offs. The investigator's objective is to establish a rational reference range of serum TSH for the diagnosis of subclinical hypothyroidism in the first, second, and third trimester of pregnant women in the Sancaktepe region in Turkey.

NCT ID: NCT04145180 Completed - Pain Clinical Trials

Effectiveness of a Physical Recovery Program for Head and Neck Cancer Patients (3C-CUIDATE)

3C-CUIDATE
Start date: September 2, 2019
Phase: N/A
Study type: Interventional

People receiving a head and neck cancer treatment often do not find an adequate therapeutic response for the side effects derived from this treatment. The objective of this study is to assess the effectiveness of a physical recovery program based on manual therapy over these problems. Previous studies have shown the effectiveness of this type of programs on patients who have had cancer in other locations with clinically relevant results. There is a shortage of proposals for this subgroup of patients that require special attention. This project intends to carry out an experimental randomized controlled study with 84 patients treated of head and neck cancer who will be assigned randomly to the study groups: a) manual therapy program or, b) control group. The assessment refers to a baseline form (at the beginning of the study), at 6 weeks and at 6 months of patient follow-up.

NCT ID: NCT01821183 Completed - Hip Injuries Clinical Trials

Strength and Strength-ratio of Hip Rotator Muscles at Soccer Players

Start date: April 2013
Phase: N/A
Study type: Observational

At this investigation we want to find out whether there is a difference in muscle strength of the internal and external rotation hip muscles between soccer players and non-soccer players caused by typical movement patterns seen in soccer sport.